proline has been researched along with Fibroma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balducci, C; Becchetti, E; Calastrini, C; Carinci, F; Dolci, C; Lilli, C; Locci, P; Lumare, E; Marinucci, L; Stabellini, G | 1 |
1 other study(ies) available for proline and Fibroma
Article | Year |
---|---|
Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Topics: Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Collagen; Fibroblasts; Fibroma; Fibromatosis, Aggressive; Fibronectins; Glycosaminoglycans; Humans; Proline; Protein Serine-Threonine Kinases; Proteoglycans; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; RNA; Selective Estrogen Receptor Modulators; Toremifene; Transforming Growth Factor beta1 | 2008 |